FBIO

Fortress Biotech, Inc.

Healthcare · Biotechnology

$172.27 sample

+0.39 (+0.23%) 1D

Market cap

$959.8B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-08

Alerts

8

Price$172.27 +9.83% 3M daily closessample

187.91156.85

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider buy: Director
Oct 06INSInsider sell: Chief Executive Officer
Sep 30INSInsider sell: EVP, Operations
Sep 23INSInsider sell: General Counsel
Sep 17INSInsider sell: EVP, Operations
Sep 08SECForm 144 filed
Aug 28INSInsider buy: Director
Aug 21INSInsider sell: Chief Financial Officer

Sign up to see the real FBIO record →

Company facts

SEC EDGAR registration

Name: Fortress Biotech, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -15sample, -100 to +100
Reporting currency: USD

Who is positioning in FBIO

sample

Insiders: 32 insider transactions over 90 days, net selling, $442.5M
Congress: 1 members traded over 90 days
Institutions · 13F: 26 funds hold $22.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$29.9B +21.5% y/y

Q4 2024Q3 2026

Inventory$17.4B +8.8% y/y

Q4 2024Q3 2026

Accounts receivable$13.3B +14.1% y/y

Q4 2024Q3 2026

Total debt$36.0B +12.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $832.1B +9.8% 3M
Sample peer B: $124.5B -5.9% 3M
Sample peer C: $157.1B +1.2% 3M
Sample peer D: $144.4B +13.3% 3M
Sample peer E: $561.1B +2.0% 3M